Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.80 (0.78%)
Bid:
100.20
Ask:
105.80
Spread: 5.60 (5.589%)
Market Cap: £170.50m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

17 May 2012 07:00

RNS Number : 5270D
Yule Catto & Co PLC
17 May 2012
 



 17 May 2012

 

Yule Catto & Co plc (the "Group") 

 

AGM & Interim Management Statement

 

At this morning's AGM of Yule Catto & Co plc, the international producer of speciality chemicals, Chairman Peter Wood will make the following statement which also comprises the Group's interim management statement for the period 1 January 2012 to date.

 

Profitability for the period was substantially ahead of prior year* and in line with the Board's expectations, in what has been a very challenging environment. The economic issues, particularly in Europe, have produced an environment of high raw material volatility and a general lack of business confidence.

 

In our Europe and North America segment, volumes in Q1 were 11% below what was a strong start to 2011, but 14% ahead of Q4 2011. Weakness was most evident in sales to the construction sector. Margin management has more than compensated for the lower volume levels, and together with the benefit of the planned synergies, the segment operating profit was substantially ahead of prior year.

 

In our Asia and ROW segment, the Construction and Coatings business unit showed good year on year improvement. However, in Health and Protection, demand remained subdued. Asia and ROW volumes were down 1% on Q1 2011 and 11 % ahead of Q4 2011. Margins in Health and Protection in the first half of 2011 were reasonably strong and have not been maintained at these high levels. Consequently results overall for the segment were below prior year.

 

Synergies hit an annualised run rate of £20 million as at the end of Marchand remain on track for £25M at the end of Q1 next year. This represents a £15M full year synergy benefit to 2012 operating profits compared to prior year.

 

The Group's latex expansion in Malaysia remains on track for production in the fourth quarter. This expansion will allow us to keep pace with long term demand in the high growth nitrile latex market and allow additional growth through the sale of locally manufactured SBR.

 

Net debt at the end of April was £171M, slightly up on the year end position of £164M

 

The Board also notes the current weakness of the euro which has hit 1.25 against sterling in recent days, having averaged 1.20 over the first four months of 2012, and 1.15 through 2011. The Group made a little over half of its operating profit in the euro zone in 2011. The translation effect of a one cent movement in the euro equates to approximately £0.5M of operating profit.

 

The environment remains both challenging and volatile. Against this background, the Board is pleased with the Group's financial performance year to date, and its expectations for the performance of the Group over the remainder of the year remain unchanged.

 

Note: * The Group reported an underlying proforma PBT of £96.0M for full year 2011, which included an adjustment to reflect the first quarter's pre acquisition operating profit of PolymerLatex of £13.3M and an estimated interest cost of £2.1M. Comments on PBT, operating profit performance and volumes for the period under review compared to 2011 are based on this proforma basis.

 

- Ends -

 

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

 

David Blackwood, Group Finance Director

 

 

 

 

MHP Communications

Tel: 020 3128 8100

Andrew Jaques

 

John Olsen

 

Ian Payne

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLFFELEVIRLIF
Date   Source Headline
6th Nov 20084:37 pmRNSPrice Monitoring Extension
21st Oct 20086:24 pmRNSHolding(s) in Company
21st Oct 20086:24 pmRNSHolding(s) in Company
8th Sep 20084:41 pmRNSSecond Price Monitoring Extn
8th Sep 20084:36 pmRNSPrice Monitoring Extension
2nd Sep 200812:26 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
14th Aug 20088:59 amRNSNotice of Results
12th Aug 20087:00 amRNSSale Completion
5th Aug 20089:42 amRNSBlocklisting Interim Review
1st Aug 200812:03 pmRNSHolding(s) in Company
21st Jul 20087:00 amRNSDisposal
27th Jun 20087:00 amRNSSale Completion
26th Jun 200810:17 amRNSHolding(s) in Company
18th Jun 200811:44 amRNSHolding(s) in Company
17th Jun 200810:12 amRNSDirector/PDMR Shareholding
16th Jun 20085:14 pmRNSDirector/PDMR Shareholding
16th Jun 200810:33 amRNSDirector/PDMR Shareholding
2nd Jun 20082:57 pmRNSBlocklisting Interim Review
30th May 20082:37 pmRNSSale Completion
15th May 20084:17 pmRNSResult of AGM
15th May 20087:00 amRNSTrading Update
9th May 20081:44 pmRNSHolding(s) in Company
24th Apr 20083:00 pmRNSAnnual Information Update
14th Apr 20084:43 pmRNSAnnual Report and Accounts
8th Apr 20089:55 amRNSDirector/PDMR Shareholding
7th Apr 20084:30 pmRNSHolding(s) in Company
14th Mar 200811:48 amRNSDirector/PDMR Shareholding
14th Mar 200811:46 amRNSDirector/PDMR Shareholding
12th Mar 20087:00 amRNSFinal Results
11th Feb 20082:40 pmRNSBlocklisting Interim Review
11th Feb 20087:01 amRNSDisposal
14th Dec 20077:00 amRNSPre-close Trading Statement
30th Nov 20073:37 pmRNSBlocklisting Interim Review
28th Nov 20072:46 pmRNSHolding(s) in Company
22nd Nov 20074:25 pmRNSDirector/PDMR Shareholding
24th Sep 200710:00 amRNSGroup Finance Director
6th Sep 20077:01 amRNSInterim Results
21st Aug 20077:00 amRNSBoard Appointments
14th Aug 20079:30 amRNSHolding(s) in Company
8th Aug 200712:16 pmRNSHolding(s) in Company
1st Aug 20077:01 amRNSPlant reorganisation
24th Jul 20072:05 pmRNSHolding(s) in Company
20th Jul 20073:50 pmRNSHolding(s) in Company
13th Jul 200712:47 pmRNSHolding(s) in Company
22nd Jun 200711:16 amRNSHolding(s) in Company
1st Jun 200711:25 amRNSBlocklisting Interim Review
1st Jun 20077:01 amRNSDivisional restructuring
29th May 20072:44 pmRNSHolding(s) in Company
17th May 20074:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.